Evidence map›Paper›PMID 41785101›Full record

ReviewCognitive behaviour therapy2026

The role of distress tolerance in treatment of posttraumatic stress and substance use disorders: a systematic review.

Christina N Gillezeau, Margo C Hurlocker

Abstract readReview
In one paragraph

Review in Cognitive behaviour therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christina N GillezeauCenter on Alcohol, Substance Use, and Addiction, Albuquerque, NM 87106, USA.ORCID 0000-0003-1318-8316
Margo C HurlockerCenter on Alcohol, Substance Use, and Addiction, Albuquerque, NM 87106, USA.ORCID 0000-0002-9744-8551

Funding

Alcohol Research Training: Methods & MechanismsT32AA018108 · NIAAA · UNIVERSITY OF NEW MEXICO · PI Katie A Witkiewitz · 2010 to 2026
$5.6M
Adapting intake procedures to improve treatment delivery in addiction treatmentK23DA052646 · NIDA · UNIVERSITY OF NEW MEXICO · PI HURLOCKER, MARGO · 2021 to 2025
$869k
NIAAA NIH HHS T32 AA018108NIDA NIH HHS K23 DA052646
6 · The paper itself

Abstract

Comorbid posttraumatic stress disorder and substance use disorder (PTSD-SUD) is associated with more severe symptoms, higher treatment dropout, and worse treatment outcomes than either condition alone. Distress tolerance (DT) is a potentially modifiable risk factor of PTSD and SUD that may impact treatment outcomes. However, little is known about changes in or impact of DT on comorbid PTSD-SUD treatment. This review identified treatment outcome studies of adult samples with SUD and diagnosis or symptoms of comorbid PTSD that examined the assessment of DT and its effects on treatment. Eight articles representing seven unique studies were included. No study included DT-specific interventions for PTSD and/or SUD, and only three examined change in DT over the course of treatment. Most studies examined DT as a predictor of premature treatment discontinuation or a baseline predictor of treatment outcomes. Though DT was not a robust predictor of treatment discontinuation and results were inconsistent on SUD outcomes, lower levels of DT predicted slower or less symptom improvement in PTSD. Future work should address DT in comorbid PTSD-SUD, identify active ingredients of current empirically supported treatments for PTSD and/or SUD, and incorporate additional DT skills into existing treatments, particularly for clients with low DT.

Indexed as

comorbidityDistress toleranceposttraumatic stress disordersubstance use disordertreatment outcomes

Identifiers

PMID41785101
PMCPMC13053029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.